Fig. 4From: Overexpression of OCT-1 gene is a biomarker of adverse prognosis for diffuse large B-cell lymphoma (DLBCL): data from a retrospective cohort of 77 Brazilian patientsProgression-free survival (PFS) in the DLBCL patients ≥60 years subgroup according to OCT-1 gene expressionBack to article page